Bortezomib Combined With DAG Regimen in the Treatment of Refractory/Relapsed AML
Clinical trial NCT05982756 · UNKNOWN
Trial details
- NCT number
- NCT05982756
- Sponsor
- Zhongnan Hospital
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-01
- Primary completion
- 2023-09-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.